Investigational ALS drug generates promising clinical trial results
AMX0035 is the first investigational therapy to demonstrate statistically significant benefit in people with ALS since approved therapies riluzole and edaravone.
Healey Center News & Events
Narrow your search for a specific article by using the search box and/or filters.
55 results
New Fellowships in ALS Research
With the help of donors including the Byrne Family, the Judith and Jean Pape Adams Foundation and the Cullen Education and Research Fund, these new young investigators will have the opportunity to play a central role in breaking down current barriers, accelerating the translation of research findings into care, and expanding treatment access to innovative and personalized therapeutic trials.
First Participants Enrolled in the Groundbreaking Trial Led by the Sean M. Healey & AMG Center for ALS at Mass General
As the first ever platform trial for ALS, the HEALEY ALS Platform Trial is testing three proposed drug regimens and will add two more over the next several months.
New studies with Sean M. Healey & AMG Center for ALS at Mass General target disease-causing gene
New studies focus on the SOD1 gene in ALS.
A Tribute to Sean M. Healey
Two years ago, Sean M. Healey became a part of the Mass General ALS family and an advocate for those with ALS. We are saddened to share the news that Sean M. Healey, our treasured partner, patient and friend passed away peacefully May 26, 2020 with his loving family by his side.
Positive Clinical Trial Result
Peer-reviewed results of a trial led by the Healey Center’s Dr. Sabrina Paganoni, will be published soon. The CENTAUR trial, highlighted in a Wall Street Journal article, tested a drug that showed promise in slowing muscle decline in individuals with ALS.
Call for Nominations: 2020 Healey Center International Prize For Innovation In ALS
The Healey Center International Prize for Innovation in ALS is an annual global prize celebrating excellence in research for a team of investigators who catalyse exceptional discoveries leading to a transformative advance in therapy development in ALS.
新型冠状病毒疫情防控期间 ALS（肌萎缩侧索硬化）患者及护理人员注意事项
以下介绍新型冠状病毒疫情可能对ALS患者的治疗护理带来的影响。
COVID-19: Información para pacientes con ELA y sus cuidadores
Aquí hay algunas respuestas a preguntas frecuentes sobre cómo el brote del COVID-19 puede afectar su tratamiento de ELA.
HEALEY ALS Platform Trial Updates and April 8th Webinar
Please join us for a conversation about the HEALEY ALS Platform Trial on Wednesday, April 8 at 3:00 pm.
Showing 1 - 10 of 55 results
Transforming Medicine Through Innovation
Research at Massachusetts General Hospital integrates the full spectrum of "bench to bedside" discovery. Laboratory scientists work collaboratively with clinicians to make discoveries and turn them into treatments, diagnostics and devices that improve our quality of life.